Cited by 44Genetic Syndromes and ImprintingBirth, Development, and HealthGestational Diabetes Research and Management

Raised Late Pregnancy Glucose Concentrations in Mice Carrying Pups With Targeted Disruption of H19 Δ 13

Open access
Petry, Clive J., Evans, Mark L., Wingate, Dianne L., Ong, Ken K., Reik, Wolf, Constância, Miguel, Dunger, David B.·2010·Diabetes

Abstract

OBJECTIVE: We have hypothesized that variation in imprinted growth-promoting fetal genes may affect maternal glucose concentrations in pregnancy. To test this hypothesis we evaluated the effects of fetal disruption of murine H19Δ13 on maternal glucose concentrations in pregnancy. RESEARCH DESIGN AND METHODS: Experimental mice were pregnant females that had inherited the disrupted H19Δ13 from their fathers and were therefore phenotypically wild type due to imprinting; approximately half of their litters were null for H19Δ13 through maternal inheritance of the disrupted gene. In control mice approximately half the litter paternally inherited the disrupted H19Δ13, so the pups were either genetically wild type or phenotypically wild type due to imprinting. Blood glucose concentrations were assessed by intraperitoneal glucose tolerance tests on days 1, 16, and 18 of pregnancy. RESULTS: There were no differences in the glucose concentrations of control and experimental pregnant mice at day 1. However, at day 16 mothers carrying H19Δ13-null pups had a significantly higher area under the glucose tolerance test curves than controls (1,845 ± 378 vs. 1,386 ± 107 mmol · min · l−1 [P = 0.01]) in association with increasing pregnancy-related insulin resistance. Although this difference lessened toward term, overall, mothers of maternally inherited H19Δ13 mutants had significantly higher glucose concentrations during the last trimester (1,602 ± 321 [n = 17] vs. 1,359 ± 147 [n = 18] mmol · min · l−1 [P = 0.009]). CONCLUSIONS: This study provides evidence that maternal glucose concentrations in pregnant mice can be affected by targeted disruption of fetal H19Δ13. This implies that variable fetal IGF2 expression could affect risk for gestational diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db09-0757

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Variations in fetal-placental growth induced genetically are known to alter the metabolic and endocrine environment of the dam.

    “In addition, variations in fetal-placental growth induced genetically are known to alter the metabolic and endocrine environment of the dam (439, 495).”

    From Placental Origins of Chronic Disease (2016) · cites this paper as [439]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Petry, C. J., Evans, M. L., Wingate, D. L., Ong, K. K., Reik, W., Constância, M., & Dunger, D. B.
Affiliations
  • University of Cambridge (GB)
  • Babraham Institute (GB)
Corresponding author
Petry, Clive J.
Venue
Diabetes
Published
2009-09-30
Volume
59
Issue
1
Pages
282-286
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2103583984
Cited by
44
References
30
Citations by year
2024: 1 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 9 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 1 · 2013: 3 · 2012: 3
FWCI
2.34
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • National Institute for Health and Care Research (NF-SI-0508-10274)
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council (BB/H003312/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
Keywords
H19, genomic imprinting, maternal blood glucose, late pregnancy, gestational diabetes mellitus, insulin-like growth factor II, insulin resistance, maternal inheritance, glucose tolerance
MeSH terms
Animals, Blood Glucose, Female, Fetus, Glucose Tolerance Test, Hyperglycemia, Insulin, Insulin-Like Growth Factor II, Male, Pedigree, Pregnancy, Pregnancy Complications, Genetic Variation, Diabetes, Gestational, Genome, Genomic Imprinting, RNA, Untranslated, Mice, RNA, Long Noncoding

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review